These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 19604045)

  • 41. [German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)].
    Brockmeyer NH; ;
    Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S7-18. PubMed ID: 12736863
    [No Abstract]   [Full Text] [Related]  

  • 42. Update of the Drug Resistance Mutations in HIV-1.
    Johnson VA; Brun-Vezinet F; Clotet B; Gunthard HF; Kuritzkes DR; Pillay D; Schapiro JM; Richman DD
    Top HIV Med; 2008 Dec; 16(5):138-45. PubMed ID: 19106428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [HIV mutant M184V. Benefits of a mutation].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():53-4. PubMed ID: 11373783
    [No Abstract]   [Full Text] [Related]  

  • 44. HIV resistance testing benefit is shown.
    AIDS Alert; 2001 Oct; 16(10):136. PubMed ID: 11590937
    [No Abstract]   [Full Text] [Related]  

  • 45. HIV/AIDS in China. A new treatment campaign, but with limited weapons.
    Cohen J
    Science; 2004 Jun; 304(5676):1433. PubMed ID: 15178778
    [No Abstract]   [Full Text] [Related]  

  • 46. Understanding the changing prevalence of K65R.
    Theys K; Vandamme AM
    AIDS Rev; 2008; 10(2):125. PubMed ID: 18615124
    [No Abstract]   [Full Text] [Related]  

  • 47. [HIV infection. Virus resistance: development and prevention].
    Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T
    Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868
    [No Abstract]   [Full Text] [Related]  

  • 48. Viral patterns of unboosted 908 identified.
    AIDS Patient Care STDS; 2003 Aug; 17(8):431. PubMed ID: 13678545
    [No Abstract]   [Full Text] [Related]  

  • 49. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment.
    Kouanfack C; Montavon C; Laurent C; Aghokeng A; Kenfack A; Bourgeois A; Koulla-Shiro S; Mpoudi-Ngole E; Peeters M; Delaporte E
    Clin Infect Dis; 2009 May; 48(9):1318-22. PubMed ID: 19320592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-resistant HIV: predicting the future.
    Laurence J
    AIDS Read; 2001 Oct; 11(10):485-6. PubMed ID: 11708079
    [No Abstract]   [Full Text] [Related]  

  • 51. Men who have sex with men, risk behavior, and HIV infection: integrative analysis of clinical, epidemiological, and laboratory databases.
    Levy I; Mor Z; Anis E; Maayan S; Leshem E; Pollack S; Chowers M; Mor O; Riesenberg K; Sthoeger Z; Ram D; Grossman Z
    Clin Infect Dis; 2011 Jun; 52(11):1363-70. PubMed ID: 21596678
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nine-year trends in clinically relevant reduced susceptibility of HIV-1 to antiretrovirals.
    Sista P; Rinehart A; Wasikowski B; Winters B; Pattery T; Bacheler L
    J Clin Virol; 2009 Mar; 44(3):190-4. PubMed ID: 19168389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of HIV drug resistance mutations: more clues from clinical observations.
    Jenny-Avital ER; Stein DK
    Clin Infect Dis; 2004 May; 38(10):1507-8. PubMed ID: 15156499
    [No Abstract]   [Full Text] [Related]  

  • 54. [Tests to detect resistance to antiretroviral agents in clinical practice].
    Seriano Vázquez V; Rodríguez-Rosado y Martínez-Echevarría R; Martínez-Echevarría
    Rev Clin Esp; 1999 Mar; 199(3):179-83. PubMed ID: 10230303
    [No Abstract]   [Full Text] [Related]  

  • 55. Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus.
    Menzo S; Vincenti D; Solmone M; Prosperi M; Bruselles A; Abbate I; Rozera G; Capobianchi MR
    J Infect Dis; 2009 Dec; 200(11):1798-9; author reply 1799-1800. PubMed ID: 19905934
    [No Abstract]   [Full Text] [Related]  

  • 56. Accommodating uncertainty in a tree set for function estimation.
    Healy BC; DeGruttola VG; Hu C
    Stat Appl Genet Mol Biol; 2008; 7(1):Article5. PubMed ID: 18312210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV/AIDS. Experts question danger of 'AIDS superbug'.
    Cohen J
    Science; 2005 Feb; 307(5713):1185. PubMed ID: 15731415
    [No Abstract]   [Full Text] [Related]  

  • 58. HIV and drug resistance - interpretation and therapeutic progress.
    Gürtler L
    Intervirology; 2012; 55(2):77-8. PubMed ID: 22286873
    [No Abstract]   [Full Text] [Related]  

  • 59. ICAAC study on resistance.
    Burgess G
    Surviv News (Atlanta Ga); 2002 Feb; ():14. PubMed ID: 11870996
    [No Abstract]   [Full Text] [Related]  

  • 60. Preclinical data released on PI.
    AIDS Patient Care STDS; 2003 Sep; 17(9):483-4. PubMed ID: 14596252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.